Researcher biography

Dr Patty Hernández Mitre is a Postdoctoral Research Fellow in the Antimicrobial Optimisation Group and team member of the CRE-RESPOND (Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal persONalised Dosing) at the University of Queensland Centre for Clinical Research (UQCCR) in Brisbane, Queensland, Australia.

Patty performs non-compartmental pharmacokinetic analysis of Phase I investigational drugs using Phoenix WinNonlin, as well as population pharmacokinetic modelling for clinical collaborators of a variety of drugs including antiepileptics, antimicrobials and antifungals, using NONMEM and Pmetrics.

She currently leads the data analysis of the Screening Anti-Fungal Exposure in Intensive Care Units (SAFE-ICU) study, a multi-national study across 12 countries that aims to develop optimised antibiotic dosing guidelines for ICU patients with life-threatening infections that account for patient characteristics.